Share This Article
This month, we celebrate with you a New Year and our 30th year in business.
What does one think when they look back at 30 years in business or 30 years of their life. ABS was founded 30 years ago this month. Was it worth it? Was it fun? Were there mistakes? For me the answer is yes to all of the above. Of course, there are things that we would do differently with the benefit of what we know today; but what we know today comes in part for those actions that we might have been done differently.
We have grown and prospered because of our service to you. We are grateful for the opportunity to work with so many fine people, both employees and clients, in pursuing our mutual goals.
Looking backward may be informative and nostalgic. Looking forward, we continue to strengthen and continuously improve our core cell culture and biospecimen offerings as we expand into new areas. In the coming months, we will elaborate on expansion plans and new ways in which we plan to serve the bioscience community.
We wish you health and happiness in the coming year and look forward to working with you this year and in those to come.
HARMINDER SINGH, M.D.
Business Development Director, ABS Bio
15+ years in life sciences
Biospecimen operations expert
Precision medicine research
Harminder Singh, M.D. is Business Development Director at ABS Bio. He joined ABS Bio from Cureline, where he was instrumental in leading biospecimen operations. He brings more than 15 years of experience in the life sciences industry and is a recognized expert in human biospecimen sourcing, management, and global clinical research. Dr. Singh is actively engaged in designing and executing research projects involving human biospecimens to help develop precision medicine therapies. He has a strong track record of building and maintaining long-term partnerships with clinical networks and pharmaceutical/biotechnology clients.
